AVR 4.08% $12.49 anteris technologies ltd

Ann: CardioCel and VascuCel rights sold to LeMaitre Vascular, page-30

  1. 839 Posts.
    lightbulb Created with Sketch. 41
    Need to read the LeMaitre PDF I posted above.

    " Admedus will continue to manufacture the products for up to three years while LeMaitre Vascular
    transitions manufacturing to its US headquarters. LeMaitre Vascular will not take ownership of the Admedus factory in Perth, Australia.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.